Universal Vision Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 835.6 million compared to TWD 610.28 million a year ago. Net income was TWD 213.34 million compared to TWD 149.44 million a year ago.

Basic earnings per share from continuing operations was TWD 2.6667 compared to TWD 1.8667 a year ago. Diluted earnings per share from continuing operations was TWD 2.6667 compared to TWD 1.8667 a year ago.